Trial intelligence / Profile preview

Flash Dose Corticosteroids in Digestive Surgical Oncology

2018-004852-39Phase 3Active

Sponsor
Centre Hospitalier Universitaire Dijon Bourgogne
Start
Mar 2019
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in gastrointestinal cancer comparing Corticosteroids arm with Placebo arm (2 arms). Primary endpoint: Major postoperative complications at 30 days. Started Mar 2019; status: active.

02

Drugs

corticosteroids
03

Conditions

gastrointestinal cancer

Beyond the preview

Go deeper on 2018-004852-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-004852-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call